Publication | Closed Access
An Activatable NIR‐II Fluorescent Reporter for In Vivo Imaging of Amyloid‐β Plaques
99
Citations
60
References
2022
Year
Vivo ImagingEngineeringNeurochemical BiomarkersBiomedical EngineeringNir-ii Fluorescent ReportersAmyloid‐β PlaquesAlzheimer's DiseaseProtein MisfoldingTranslational Molecular ImagingBioimagingMolecular ImagingBiophysicsNovel Imaging MethodBiomedicineAd ProgressionFluorescence ImagingBiophotonicsNeurodegenerative DiseasesBiomedical DiagnosticsCellular NeuroscienceBiomedical ImagingBiomarkersNeuroscienceMedicineSmall Molecules
Fluorescence imaging in the second near-infrared (NIR-II) window holds great promise for in vivo visualization of amyloid-β (Aβ) pathology, which can facilitate characterization and deep understanding of Alzheimer's disease (AD); however, it has been rarely exploited. Herein, we report the development of NIR-II fluorescent reporters with a donor-π-acceptor (D-π-A) architecture for specific detection of Aβ plaques in AD-model mice. Among all the designed probes, DMP2 exhibits the highest affinity to Aβ fibrils and can specifically activate its NIR-II fluorescence after binding to Aβ fibrils via suppressed twisted intramolecular charge transfer (TICT) effect. With suitable lipophilicity for ideal blood-brain barrier (BBB) penetrability and deep-tissue penetration of NIR-II fluorescence, DMP2 possesses specific detection of Aβ plaques in in vivo AD-model mice. Thus, this study presents a potential agent for non-invasive imaging of Aβ plaques and deep deciphering of AD progression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1